Medco Announces Two-For-One Stock Split(statements due to anumber of factors. Th...),Health

-- Competition in the PBM, specialty pharmacy and the broader health care

industry is intense and could impair our ability to attract and retain

clients;

-- Failure to retain key clients could result in significantly decreased

revenues and could harm our profitability;

-- If we do not continue to earn and retain purchase discounts and rebates

from manufacturers at current levels, our gross margins may decline;

-- Our acquisition activity increased recently and if we are unable to

effectively integrate acquired businesses into ours, our operating

results may be adversely affected;

-- If we fail to comply with complex and rapidly evolving laws and

regulations, we could suffer penalties, or be required to pay

substantial damages or make significant changes to our operations;

-- Government efforts to reduce health care costs and alter health care

financing practices could lead to a decreased demand for our services

or to reduced profitability;

-- Failure to execute our Medicare Part D prescription drug benefits

strategy could adversely impact our business and financial results;

-- PBMs could be subject to claims under ERISA if they are found to be a

fiduciary of a health benefit plan governed by ERISA;

-- Pending litigation could adversely impact our business practices and

have a material adverse effect on our business, financial condition,

liquidity and operating results;

-- We are subject to corporate integrity agreements and noncompliance may

impede our ability to conduct business with the federal government;

-- Legislative or regulatory initiatives that restrict or prohibit the PBM

industry's ability to use patient identifiable medical information

could limit our ability to use inf
'/>"/>